EpiBiologics

EpiBiologics develops first-in-class antibody based targeted therapies against membrane and extracellular proteins that drive underlying disease biology.


Founded
2022
Headcount
31
Open roles
0
Last raised
Series A · $23M

SECTION I · THE BRIEF

Inside EpiBiologics

Brief #94607Updated 18 NOV 2025SAN MATEOGVSERIES A
Employbl Dossier

EpiBiologics

EpiBiologics develops first-in-class antibody based targeted therapies against membrane and extracellular proteins that drive underlying disease biology.

Founded
2022
Headcount
31
Open roles
0
Last raised
Series A · $23M
Section II — RestrictedMembers only
  • Engineering interview process at EpiBiologics
  • Tech stack & infrastructure choices
  • Culture & day-to-day work style
  • Why join now vs. 6 months from now
  • Hiring focus & open headcount by team
  • Comp philosophy and band context

7-day free trial · $25/mo · cancel anytime


OPEN ROLES

Hiring at EpiBiologics

Current Job Listings

Listing 0 of 0 job openings
We don't currently have any jobs listed for this company. We suggest visiting the Jobs Search page if you are looking for exciting new tech and startup opportunities.

FUNDING

Capital raised

Total Amount Raised: $96,050,000

EpiBiologics' Investors

EpiBiologics Funding Rounds

  • Series A

    $23,000,000

  • Series A

    $23,000,000

    Series A Investors

    Codon Capital
    Taiho Ventures
    Digitalis Ventures
    Mubadala Capital Ventures
    Polaris Partners
    Vivo Capital
    GV
  • Series A

    $73,050,000

  • Series A

    $73,050,000

    Series A Investors

    Mubadala Capital Ventures
    Polaris Partners
    Vivo Capital
    GV
Funding info provided by Diffbot.

TAGS

Categorized in

Company Collections

These are collections EpiBiologics is a part of. Click on the collection name to view similar companies.

EpiBiologics' Investors


LOCATIONS

Where they work

EpiBiologics Headquarters Location

1900 Alameda De Las Pulgas suite 250, San Mateo, CA, 94403

Loading map…